Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Cash from Operations (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Cash from Operations for 3 consecutive years, with 29700000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 35.86% to 29700000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 173400000.0 through Dec 2025, down 32.96% year-over-year, with the annual reading at 173400000.0 for FY2025, 32.96% down from the prior year.
  • Cash from Operations for Q4 2025 was 29700000.0 at Nuvation Bio, up from 52895000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 15029000.0 in Q4 2023, with the low at 52895000.0 in Q3 2025.
  • Average Cash from Operations over 3 years is 30984333.33, with a median of 30392500.0 recorded in 2024.
  • The sharpest move saw Cash from Operations tumbled 208.08% in 2024, then skyrocketed 35.86% in 2025.
  • Over 3 years, Cash from Operations stood at 15029000.0 in 2023, then crashed by 208.08% to 46302000.0 in 2024, then surged by 35.86% to 29700000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 29700000.0, 52895000.0, and 48178000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.